FILE PHOTO: An employee works inside a laboratory at Piramal’s Research Centre in Mumbai August 11, 2014. Indian drugmakers are fleeing a regulatory morass at home and moving some research and development to Europe and the United States as they try to boost margins by producing high-value drugs. Companies like Piramal Enterprises Ltd, Sun Pharmaceutical Industries Ltd and Lupin Ltd are investing millions of dollars and placing their future growth in foreign regulators’ hands, as they seek to add more complex drugs to their product lines. Picture taken August 11, 2014. To match INDIA-PHARMACEUTICALS/RESEARCH/ REUTERS/Danish Siddiqui/FIle Photo